Digest Network Come funziona
Network
/
Società
Ar
Non verificato

Artis BioSolutions

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteScienza

5 comunicati stampa

Guarda tutti i comunicati
26/08/2026
Mercato del lavoro
Industria
Biotecnologia
Farmaceutica
Salute
Artis BioSolutions Launches mRNA and Lipid Nanoparticle Manufacturing Capabilities at New “Genetic Medicines Center of Excellence” in Bilbao, Spain
Fonte
Artis BioSolutions
Emittente
Business Wire
1.00
0
29/07/2026
Industria
Information Technology
Tecnica
Salute
Sanità
Scienza
Software
Biotecnologia
Landmark Bio and Syngoi Technologies to Operate as Artis BioSolutions, an End-to-end Gene-to-GMP Platform for Genetic Medicines
Fonte
Artis BioSolutions
Emittente
Business Wire
1.00
0
24/03/2026
Industria
Salute
Biotecnologia
Scienza
Farmaceutica
Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston
Fonte
Artis BioSolutions
Emittente
Business Wire
1.00
0
17/02/2026
Oncologia
Salute
Biotecnologia
Sanità
Medicina - Varie
Farmaceutica
Mercato del lavoro
Artis BioSolutions Appoints Dr. Kate Broderick, Ph.D., as Chief Scientific Innovation Officer to Advance Synthetic DNA Strategy
Fonte
Artis BioSolutions
Emittente
Business Wire
1.00
0
06/01/2026
Salute
Biotecnologia
Scienza
Farmaceutica
Mercato azionario
Artis BioSolutions Announces Agreement to Acquire Syngoi Technologies to Deliver Next Generation Solutions for Synthetic DNA Technology
Fonte
Artis BioSolutions
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0